Inhibiting the expression of USF1 could reduce the migration and invasion abilities of glioma cells, while overexpressing HAS2-AS1 could recover the inhibitory effects of USF1 on glioma cells to a certain extent. The gene discussed is HAS2; the disease is glioma.